3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Opioid-Related Disorders

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with Opioid-Related Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bespalov, AIu; Zvartau, EE	1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Opioid-Related Disorders

Article	Year
[NMDA-receptor antagonists: new pharmacological agents to control the subjective and motivational effects of narcotics]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 1998, Issue:11 Topics: Animals; Conditioning, Classical; Discrimination Learning; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Mice; Motivation; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pipecolic Acids; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate; Recurrence; Substance Withdrawal Syndrome	1998

Article

Year

[NMDA-receptor antagonists: new pharmacological agents to control the subjective and motivational effects of narcotics].

Vestnik Rossiiskoi akademii meditsinskikh nauk, 1998, Issue:11

Topics: Animals; Conditioning, Classical; Discrimination Learning; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Mice; Motivation; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pipecolic Acids; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate; Recurrence; Substance Withdrawal Syndrome

1998